CVR: 41120495
BOOST Pharma ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans Thalsgård Schambye. The company is owned by BOOST Pharma AB. In 2025, the company reported a gross profit of DKK -7,557,572 and a net result of DKK -9,243,488 compared with DKK -4,259,583 the year before. Equity amounted to DKK -11,850,535.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at forske, udvikle og tilvejebringe lægemidler.
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationCompared to 1.053 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
BOOST Pharma ApS has published its annual report for 2025. Gross profit came to DKK -7,557,572, and the net result was DKK -9,243,488.
As of June 17, 2026, Hans Thalsgård Schambye has left the board of directors of BOOST Pharma ApS.
As of June 17, 2026, Ingelise Saunders has left the board of directors of BOOST Pharma ApS.
As of June 17, 2026, Lars Magnus Reinhold Westgren has left the board of directors of BOOST Pharma ApS.
As of June 17, 2026, Jonathan Jossi Ilicki has left the board of directors of BOOST Pharma ApS.
As of June 17, 2026, John Öhd has left the board of directors of BOOST Pharma ApS.
As of February 16, 2026, Hans Thalsgård Schambye is registered as adm. dir. of BOOST Pharma ApS.
As of February 16, 2026, Ingelise Saunders has stepped down as adm. dir. of BOOST Pharma ApS.
Address changed to Nordre Fasanvej 215 215, 2000 Frederiksberg (February 5, 2026).
As of October 30, 2025, is registered as an owner of BOOST Pharma ApS with an ownership share of 100%.
As of August 22, 2025, Hans Thalsgård Schambye has joined the board of directors of BOOST Pharma ApS.
BOOST Pharma ApS has published its annual report for 2024. Gross profit came to DKK -2,193,394, and the net result was DKK -4,259,583.
As of October 1, 2024, Ingelise Saunders is registered as adm. dir. of BOOST Pharma ApS.
As of September 30, 2024, Everhardus Johannes Joseph Kueppers has stepped down as director of BOOST Pharma ApS.
As of August 26, 2024, Jonathan Jossi Ilicki has joined the board of directors of BOOST Pharma ApS.
As of August 26, 2024, Jonas Jendi has left the board of directors of BOOST Pharma ApS.
BOOST Pharma ApS has published its annual report for 2023. Gross profit came to DKK -1,529,771, and the net result was DKK -2,753,145.
As of June 25, 2024, Jonas Jendi has joined the board of directors of BOOST Pharma ApS.
As of June 25, 2024, Jonathan Jossi Ilicki has left the board of directors of BOOST Pharma ApS.
As of June 1, 2024, Everhardus Johannes Joseph Kueppers is registered as director of BOOST Pharma ApS.
As of June 1, 2024, Ingelise Saunders has stepped down as director of BOOST Pharma ApS.
As of May 23, 2024, Jonathan Jossi Ilicki has joined the board of directors of BOOST Pharma ApS.
As of May 23, 2024, John Öhd has joined the board of directors of BOOST Pharma ApS.
BOOST Pharma ApS has published its annual report for 2022. Gross profit came to DKK -3,499,684, and the net result was DKK -4,197,998.
BOOST Pharma ApS has published its annual report for 2021. Gross profit came to DKK -1,319,978, and the net result was DKK -2,224,194.
As of February 9, 2022, Ingelise Saunders is registered as director of BOOST Pharma ApS.
As of February 9, 2022, Lilian Karin Florence Walter Jallow has stepped down as director of BOOST Pharma ApS.
As of May 1, 2021, Ingelise Saunders has joined the board of directors of BOOST Pharma ApS.
As of May 1, 2021, Lars Magnus Reinhold Westgren has joined the board of directors of BOOST Pharma ApS.
As of May 1, 2021, Anna Cecilia Götherström has stepped down as director of BOOST Pharma ApS.
As of May 1, 2021, Lars Magnus Reinhold Westgren has stepped down as director of BOOST Pharma ApS.
BOOST Pharma ApS has published its annual report for 2020. Gross profit came to DKK -20,919, and the net result was DKK -63,347.
As of February 22, 2021, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of BOOST Pharma ApS.
As of January 20, 2020, Lilian Karin Florence Walter Jallow is registered as director of BOOST Pharma ApS.
As of January 20, 2020, Anna Cecilia Götherström is registered as director of BOOST Pharma ApS.
As of January 20, 2020, Lars Magnus Reinhold Westgren is registered as director of BOOST Pharma ApS.
BOOST Pharma ApS was founded on January 20, 2020.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 40766383
CVR 42731323
CVR 38599119
companydata.dk